Keyphrases
Active Treatment
20%
Alternative Care
20%
Best Alternative
20%
Best Medical Treatment
20%
Chemoembolization
20%
Effective Management
20%
Fotemustine
20%
Hepatic Arterial Chemoembolization
20%
Hepatic Arterial Infusion Chemotherapy
20%
Hepatic Metastasis
20%
Hepatic Perfusion
20%
Hepatic Resection
60%
Improved Outcomes
20%
Intra-arterial Delivery
20%
Intravenous Delivery
20%
Liver
100%
Liver Involvement
20%
Locoregional Treatment
20%
Long-term Survival
20%
Low-volume Metastasis
20%
Melanoma
40%
Metastatic Melanoma
100%
Ocular Melanoma
60%
Overall Survival Analysis
20%
Patient Selection
40%
Percutaneous Hepatic Perfusion
20%
Phase II Study
40%
Phase II Trial
20%
Progression-free Survival
20%
Randomized Phase III Trial
20%
Survival Benefit
20%
Systemic Agents
20%
Systemic Therapy
20%
Systemic Treatment
40%
Therapeutic Challenges
20%
Therapeutic Potential
100%
Treatment Options
40%
Uncontrolled Study
20%
Unresectable Metastases
20%
Medicine and Dentistry
Cutaneous Melanoma
100%
Eye Melanoma
100%
Fotemustine
33%
Hepatectomy
100%
Intraarterial Drug Administration
33%
Liver Metastasis
33%
Long Term Survival
33%
Malignant Neoplasm
33%
Melanoma
66%
Metastatic Carcinoma
66%
Metastatic Melanoma
100%
Overall Survival
33%
Progression Free Survival
33%
Survival Analysis
33%
Systemic Therapy
100%
Transcatheter Arterial Chemoembolization
66%